Blog - Page 3753 of 5384

ThursdayOct 08, 2009 2:47 pm

Gold Crest Mines, Inc. (GCMN.OB) Up 103.13% After Recent Mention by QualityStocks

Gold Crest Mines Inc. (OTCBB: GCMN) shares traded earlier today at $0.00325 a share, rocketing higher by 103.13%. This sharp upward movement in price has been accompanied by large volume in excess of 450,000 shares, which is well above the average daily trading volume of less than 15,000 shares. Gold Crest Mines was highlighted recently in the September 10th edition of the QualityStocks Daily Newsletter at a price of only $0.01 per share. Gold Crest Mines is a US-based junior exploration focused on precious metals exploration. The company seems to be benefiting from gold's recent rise to record highs of…

ThursdayOct 08, 2009 12:51 pm

Initial Jobless Claims Decline to January Levels

A Labor Department report issued Thursday Oct. 8 shows initial claims for unemployment fell 33,000 from the prior week’s revised total to 521,000, the lowest level since the beginning of 2009. This figure was 19k less than the Thomson Reuters survey, giving some cause for hope amid a generally depressed economic outlook. With the four-week average down to 539,750, there is strong evidence of a recovery in the labor market to many investors. The second lowest point this year being reached, on the graph of this closely watched statistic, indicates too many economists that the propensity for hiring by companies…

ThursdayOct 08, 2009 12:24 pm

General Environmental Management, Inc. (GEVI.OB) Reports Progress on Plan to Expand Into Higher Margin Markets

Recently the board of directors of General Environmental Management Inc. decided to shift the company's business focus from hazardous waste field services to the higher-margin and faster-growing water treatment and waste-to-energy markets, while also reducing the company's debt. General Environmental believes it has one of the best managed and operated field services businesses in the country. This business has handled waste streams from some of the biggest companies in the country. The company is now focused on how to maximize the value of that business while it builds its high margin water treatment business and explores opportunities in the waste-to-energy…

ThursdayOct 08, 2009 10:32 am

Watching Bonds and Treasury Notes

The bond and treasury markets are at times confusing to investors. Generally they are considered a safe form of income in relatively stable economic times. Investors enjoy a small but stable flow of income. In today's environment, however, there may be a bit of uncertainty. The Federal Reserve has reduced interest rates to help spur the economy, thus making treasury notes and bonds more attractive. Unfortunately, this same agency has also issued quite a bit of debt, as it relates to the "rescue package." Generally speaking, this means that at some point interest rates will need to rise to keep…

ThursdayOct 08, 2009 10:26 am

Advanced Visual Systems, Inc. (AVSC.PK) Makes Data Visible

Advanced Visual Systems, an industry-leading data visualization software company, provides a fundamental product, applicable to virtually any type of business or technical environment. AVS products allow users to express any type and quantity of data as highly interactive 2D and 3D presentations. These capabilities can also be integrated with new or existing applications. A prime example of the AVS offering portfolio is OpenViz, a high-powered data visualization engine. OpenViz fully leverages the power of the Internet as an open and standards-based development system, allowing the conversion of any type or volume of corporate data into easily understood visualizations. Designed for…

ThursdayOct 08, 2009 10:23 am

Emisphere Technologies, Inc. (EMIS.OB) Introduces First Commercially Available Product

Emisphere Technologies Inc. announced today that the company is introducing and launching its first commercially available product, oral Eligen B12 (100 mcg). This product has been specifically developed to help improve Vitamin B12 absorption and bioavailability with a patented formulation. In a trial with healthy subjects conducted last year, Eligen B12 resulted in a ten-fold increase in peak serum B12 blood levels, a two-fold improvement in total bioavailability and a reduction in absorption time greater than 90% as compared to standard oral commercial formulations. Eligen B12 has impressed others in the nutritional field. Dr. Michael Rothkopf, M.D., the director of…

ThursdayOct 08, 2009 9:33 am

Helen of Troy Ltd. (HELE) Posts Q2, Half-Year Results with Record Sales

Helen of Troy Ltd. designs, develops and markets brand-name personal care and household consumer products. The company yesterday announced its financial results for the second quarter and half-year ended August 31, 2009, posting increases in net earnings and record sales. The company posted second-quarter sales at $162.19 million, up 5.6 percent from $153.54 million for the second quarter of 2008. Second-quarter net earnings were $15.91 million, or $0.51 per fully diluted share, as compared to $10.60 million, or $0.34 per fully diluted share, for the same period last year. The company reported sales for the six months ended August 31,…

ThursdayOct 08, 2009 9:29 am

AVANIR Pharmaceuticals, Inc. (AVNR) Receives U.S. Patent for Zenvia™

AVANIR Pharmaceuticals, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders, recently announced that the company has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) for its lead drug candidate Zenvia™, a treatment pseudobulbar affect (PBA). This patent will provide AVANIR Pharmaceuticals commercial exclusivity for PBA indication well into 2025. AVANIR Pharmaceuticals also has exclusive rights to other patents and patent applications for treating PBA, chronic pain and other neurologic conditions using combinations of dextromethorphan and quinidine. Greg Flesher, vice president of…

ThursdayOct 08, 2009 9:26 am

Hana Biosciences, Inc. (HNAB.OB) Announces $12.4 Million Private Placement

Hana Biosciences is a company that is clearly moving in the right direction. The company's lead product candidate, Marquibo, has been developed to help all cancer patients battle the deadly disease and with news released today, the concept has a great deal of backing. The young California Company announced there is a definite agreement in place with accredited investors to sell units consisting of common stocks and warrants which will result in total cash proceeds of $12.4 million the closing of which is expected to occur prior to October 9th with Piper Jaffray and Co. serving as exclusive place agent…

ThursdayOct 08, 2009 8:59 am

Rahaxi, Inc. (RHXI.OB) Announces Agreement with Largest Jeweller Group in Scandinavia

Rahaxi, Inc., an international card payments processor and technology company, today told investors that its subsidiary Rahaxi Processing Oy and jeweller chain giant Kultajousi Oy have entered into an agreement to supply its OTI solution to over 60 different stores in 27 different cities in Finland. Kultajousi is owned by Golden Heights Group which has a notable presence in Sweden through its subsidiary Golden Heights AB Group. Fionn Stakelum, MD of Rahaxi, Inc. stated, "To team up with the largest high end jewellers in Scandinavia is testament to the reputation of Rahaxi's OTI solution in the marketplace. Enabling us to…

Site Search

Company Search